Healio

Lirentelimab safe, effective in long-term gastritis, duodenitis treatment

Please provide your email address to receive an email when new articles are posted on . Lirentelimab was safe and effective in the long-term treatment of patients with eosinophilic gastritis and/or ...
Yahoo Finance

Results from Prospective Prevalence Study Indicate that Eosinophilic Gastritis and Eosinophilic Duodenitis May be Significantly Underdiagnosed

REDWOOD CITY, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast ...
Yahoo Finance

Allakos Announces Presentation from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting

REDWOOD CITY, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related ...
Nasdaq

Allakos Presents Data at ACG 2021 from Prospective Study Showing High Prevalence Rates of Eosinophilic Gastritis and/or Eosinophilic Duodenitis with Systematic Evaluation

– Study shows 45% (181/405) of patients with moderate-to-severe unexplained gastrointestinal symptoms who underwent upper endoscopy with biopsy met the histologic criteria for eosinophilic gastritis ...
Nasdaq

Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies

REDWOOD CITY, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell related ...
Daily Express

Piers Morgan health: Broadcaster quips ‘Brexit’ is to blame for his hospitalisation

Piers Morgan, 53, has established himself in the field of journalism and often tries his hand at comedy too. He routinely mines current events for his comedic material - a style that often lands him ...
Business Insider

Results from Prospective Prevalence Study Indicate that Eosinophilic Gastritis and Eosinophilic Duodenitis May be Significantly Underdiagnosed

-- 45% (181/405) ofsymptomatic patients biopsied with chronic functional gastrointestinal symptoms met the histologic criteria for eosinophilic gastritis and/or eosinophilic duodenitis -- -- ...